Immune checkpoint inhibitors and cancer-related cognitive decline: a propensity score matched analysis in active chemotherapy patients

Our findings suggest that combining chemotherapy with ICIs may exacerbate CRCD compared to chemotherapy alone. However, reliance on screening tools and self-reported measures limits definitive conclusions. Future studies incorporating comprehensive neuropsychological assessments are warranted. This study underscores the importance of using comprehensive cognitive assessments in future research to better understand the impact of ICIs on cognitive function.

Authors

Institutions

Publication Details

Journal
Frontiers in Immunology
Published
2025-03-07
DOI
https://doi.org/10.3389/fimmu.2025.1540442
Citations
2
Primary Topic
Cancer-related cognitive impairment studies
Type
article
Field-Weighted Citation Impact
3.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immune checkpoint inhibitors and cancer-related cognitive decline: a propensity score matched analysis in active chemotherapy patients

Guanqing Zhong, Nianqi Liu, Yu Si Niu, Can-Tong Liu et al.
2 citations
Frontiers in Immunology
Cancer-related cognitive impairment studies
3.04
article

Immune checkpoint inhibitors and cancer-related cognitive decline: a propensity score matched analysis in active chemotherapy patients

Guanqing Zhong, Nianqi Liu, Yu Si Niu, Can-Tong Liu, Zong-Qing Zheng, Jun Lü, Jiling Zeng, Yifei Ma, Fadian Ding, Jing‐Jer Lin, Pengfei Zhu, Yongluo Jiang, Guangmin Jian, Xinjia Wang, Yiming Li, Weidong Wang, Ao Zhang, Qi Xin, Tong Huang, Youlong Wang, Weizhi Liu, Z. Chai
article en
2 citations

Abstract

Our findings suggest that combining chemotherapy with ICIs may exacerbate CRCD compared to chemotherapy alone. However, reliance on screening tools and self-reported measures limits definitive conclusions. Future studies incorporating comprehensive neuropsychological assessments are warranted. This study underscores the importance of using comprehensive cognitive assessments in future research to better understand the impact of ICIs on cognitive function.

Frontiers in ImmunologyVol. 16
Fujian Medical University (CN), Sun Yat-sen University (CN), Second Military Medical University (CN), Capital Medical University (CN), Dallas County (US), Chinese PLA General Hospital (CN), Shantou University (CN), Beijing Tian Tan Hospital (CN), Cancer Hospital of Shantou University Medical College (CN), Jiangxi Maternal and Child Health Hospital (CN), First Affiliated Hospital of Shantou University Medical College (CN), Second Affiliated Hospital of Shantou University Medical College (CN), First Affiliated Hospital of Fujian Medical University (CN), Hainan General Hospital (CN), Hainan 301 Hospital (CN), Sun Yat-sen University Cancer Center (CN), First Affiliated Hospital of Zhengzhou University (CN), Huazhong University of Science and Technology (CN)
Openalex Percentile: Top 11%
Cancer-related cognitive impairment studies
3.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.